We are live on
!
Find out more
PAM
Panagora Asset Management Portfolio holdings
AUM
$32.6B
1-Year Est. Return
52.29%
This Fund
S&P 500
This Quarter
Est. Return
-1.37%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$18.4B
AUM Growth
-$521M
(-2.8%)
Cap. Flow
+$339M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
24.68%
Holding
1,660
New
130
Increased
801
Reduced
372
Closed
146
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$61.5M |
| 2 |
Merck
MRK
|
+$58.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$56.5M |
| 4 |
Lockheed Martin
LMT
|
+$49.7M |
| 5 |
Chubb
CB
|
+$49.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$76.2M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.4M |
| 3 |
Goldman Sachs
GS
|
+$60.9M |
| 4 |
Intuit
INTU
|
+$57.5M |
| 5 |
Deere & Co
DE
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.9% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 12.63% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HARP
1326
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $347K | ﹤0.01% |
6,974
-1,532
| -18% | -$79.4K |
|
|
DQ
1327
Daqo New Energy
DQ
$996M
| $345K | ﹤0.01% |
8,344
+1,296
| +18% | +$54.5K |
|
1328
Minerals Technologies
MTX
$2.34B
| $345K | ﹤0.01% |
5,216
| – | – |
|
1329
BorgWarner
BWA
$13.9B
| $342K | ﹤0.01% |
9,979
-467
| -4% | -$17.4K |
|
1330
Onto Innovation
ONTO
$15.3B
| $341K | ﹤0.01% |
3,927
| – | – |
|
1331
Affirm
AFRM
$25.2B
| $340K | ﹤0.01% |
+7,346
| New | +$384K |
|
1332
Landstar System
LSTR
$6.21B
| $339K | ﹤0.01% |
2,245
+1,045
| +87% | +$166K |
|
1333
TotalEnergies
TTE
$190B
| $339K | ﹤0.01% |
+6,709
| New | +$363K |
|
1334
Webster Financial
WBS
$12.8B
| $338K | ﹤0.01% |
+6,021
| New | +$357K |
|
|
SMED
1335
DELISTED
Sharps Compliance Corp
SMED
| $336K | ﹤0.01% |
56,993
-17,207
| -23% | -$108K |
|
1336
Global Water Resources
GWRS
$219M
| $335K | ﹤0.01% |
20,156
-3,192
| -14% | -$50.1K |
|
|
NXRT
1337
NexPoint Residential Trust
NXRT
$652M
| $335K | ﹤0.01% |
+3,708
| New | +$309K |
|
|
KYNB
1338
Kyntra Bio
KYNB
$29.4M
| $333K | ﹤0.01% |
+1,109
| New | +$387K |
|
1339
Ciena
CIEN
$58.4B
| $325K | ﹤0.01% |
5,359
-13,889
| -72% | -$909K |
|
1340
Precision BioSciences
DTIL
$207M
| $323K | ﹤0.01% |
3,494
-2,514
| -42% | -$342K |
|
1341
Annaly Capital Management
NLY
$17.4B
| $323K | ﹤0.01% |
11,467
| – | – |
|
1342
Daily Journal
DJCO
$778M
| $321K | ﹤0.01% |
1,028
-596
| -37% | -$194K |
|
|
AMK
1343
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $321K | ﹤0.01% |
+14,434
| New | +$340K |
|
1344
Envista
NVST
$4.52B
| $319K | ﹤0.01% |
6,543
+490
| +8% | +$22.6K |
|
1345
Primerica
PRI
$9.89B
| $318K | ﹤0.01% |
2,324
| – | – |
|
1346
Rayonier
RYN
$6.55B
| $316K | ﹤0.01% |
8,462
| – | – |
|
1347
Aecom
ACM
$9.75B
| $315K | ﹤0.01% |
4,097
+111
| +3% | +$8.15K |
|
1348
Peoples Bancorp
PEBO
$1.47B
| $314K | ﹤0.01% |
10,022
| – | – |
|
|
SF
1349
Stifel
SF
$12.6B
| $313K | ﹤0.01% |
6,906
-27,099
| -80% | -$1.3M |
|
1350
Toll Brothers
TOL
$14.5B
| $310K | ﹤0.01% |
6,592
+480
| +8% | +$26.9K |
|
Similar funds
GAM
PPF
Panagora Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Panagora Asset Management held 1,660 positions worth $18.4B, down 2.8% from $18.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Panagora Asset Management's Q1 2022 filing shows 130 new, 801 increased, 372 reduced and 146 closed positions. Its largest new stake was Performance Food Group: 453,149 shares worth $23.1M. The largest sale was JPMorgan Chase, an estimated $76.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Panagora Asset Management's largest Q1 2022 buy was Performance Food Group: 453,149 shares worth $23.1M.
- Panagora Asset Management added most to LyondellBasell Industries in Q1 2022, an estimated $61.5M increase.
- Panagora Asset Management's biggest Q1 2022 reduction was JPMorgan Chase, cutting an estimated $76.2M.
- Panagora Asset Management fully exited Xilinx Inc in Q1 2022, selling an estimated $43.2M.
- Panagora Asset Management's ten largest holdings make up 25% of its $18.4B portfolio in Q1 2022.
- Panagora Asset Management opened 130 new positions and closed 146 in Q1 2022.
- Panagora Asset Management's portfolio value fell 2.8% quarter-over-quarter to $18.4B.
Based on Panagora Asset Management's 13F filing for Q1 2022, filed 12 May 2022.